Latest drug prices and trends for NDC 42291-0822

Subscribe to access the full database, or Try for Free
Drug Name	NDC	Price/Unit ($)	Unit	Date
No data available in table
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Subscribe to access the full database, or Try for Free

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
TERAZOSIN HCL 5MG CAP	AvKare, LLC	42291-0822-10	1000	167.58	0.16758	2023-06-15 - 2028-06-14	FSS
TERAZOSIN HCL 5MG CAP	AvKare, LLC	42291-0822-10	1000	89.20	0.08920	2023-06-22 - 2028-06-14	FSS
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

The pharmaceutical industry is undergoing significant transformations, with drug pricing and market dynamics at the forefront of these changes. In this comprehensive analysis, we'll explore the market trends and price projections for the National Drug Code (NDC) 42291-0822, offering insights into its future trajectory within the evolving pharmaceutical landscape.

Understanding NDC 42291-0822

NDC 42291-0822 is a unique identifier assigned to a specific drug product. While the search results don't provide specific information about this particular NDC, we can analyze broader market trends and pricing dynamics that are likely to affect similar products in the pharmaceutical industry.

The National Drug Code System: A Brief Overview

Before delving into market analysis, it's crucial to understand the NDC system. The FDA's National Drug Code Directory contains information about finished drug products, unfinished drugs, and compounded drug products[1]. Each drug is identified by a unique three-segment number, which serves as the FDA's identifier for drugs.

Structure of the NDC

The NDC is composed of three segments:

Labeler code: Assigned by the FDA
Product code: Identifies strength, dosage form, and formulation
Package code: Identifies package sizes and types

Importance of the NDC System

The NDC system plays a vital role in drug identification, tracking, and pricing. It enables healthcare providers, insurers, and regulatory bodies to accurately identify and monitor pharmaceutical products throughout the supply chain.

Current Pricing Trends in the Pharmaceutical Industry

To understand the potential pricing trajectory of NDC 42291-0822, we must examine the broader pricing trends in the pharmaceutical sector.

Recent Price Increase Patterns

According to a recent analysis by the Office of the Assistant Secretary for Planning and Evaluation (ASPE):

In January 2022, the average price increase was nearly $150 per drug (10.0 percent), and in July 2022, it was $250 (7.8 percent)[2].

This trend suggests that pharmaceutical companies are continuing to implement significant price increases, often exceeding the rate of inflation.

Factors Influencing Drug Pricing

Several factors contribute to drug pricing decisions:

Research and development costs
Manufacturing expenses
Market competition
Regulatory requirements
Patent exclusivity periods
Demand and perceived value

Market Dynamics Shaping Pharmaceutical Pricing

The pharmaceutical market is experiencing several key trends that are likely to impact pricing strategies for drugs like NDC 42291-0822.

Increased Focus on Value-Based Pricing

Payers and healthcare systems are increasingly demanding evidence of a drug's value in terms of patient outcomes. This shift towards value-based pricing may influence how pharmaceutical companies set and adjust their prices.

Generic Competition and Price Erosion

The entry of generic competitors can significantly impact the pricing of brand-name drugs. According to ASPE:

Prices continue to decline by 70% to 80% relative to the pre-generic entry price in markets of 10 or more competitors following 3 years after first generic entry[4].

This trend underscores the importance of patent protection and market exclusivity in maintaining higher prices for brand-name drugs.

Policy and Regulatory Influences

Government policies and regulations play a crucial role in shaping pharmaceutical pricing. The implementation of the Medicare Drug Price Negotiation Program, set to begin in January 2026, is expected to have a significant impact on drug prices[6].

Projecting Future Prices for NDC 42291-0822

While specific projections for NDC 42291-0822 are not available in the search results, we can infer potential pricing trends based on industry-wide patterns.

Short-Term Price Projections

In the short term, it's likely that NDC 42291-0822 will follow the industry trend of regular price increases. If it aligns with the average increases observed in 2022, we might expect:

Annual increases of 7-10%
Potential for larger increases if the drug offers significant therapeutic advantages

Long-Term Price Considerations

Looking towards 2025 and beyond, several factors could influence the pricing of NDC 42291-0822:

Patent expiration and generic entry
Therapeutic advancements in its drug class
Changes in reimbursement policies
Implementation of drug price negotiation programs

The Impact of Generic Competition

The entry of generic competitors can dramatically alter the pricing landscape for a drug. If NDC 42291-0822 faces generic competition in the coming years, we can expect significant price erosion.

Potential Price Erosion Scenarios

Based on the ASPE analysis, we can project the following scenarios:

With 3 competitors: Approximately 20% price reduction
With 10+ competitors: 70-80% price reduction within 3 years

These projections highlight the importance of market exclusivity in maintaining higher prices for brand-name drugs.

Technological Advancements and Pricing Strategies

The pharmaceutical industry is increasingly leveraging technology to optimize pricing strategies and improve market competitiveness.

AI and Data-Driven Pricing

Artificial intelligence and big data analytics are enabling pharmaceutical companies to:

Predict market demand more accurately
Optimize pricing strategies in real-time
Identify price sensitivities across different market segments

Blockchain for Transparent Pricing

Blockchain technology has the potential to increase transparency in pharmaceutical pricing by:

Tracking drug supply chains
Providing immutable records of price changes
Facilitating more efficient price negotiations between manufacturers and payers

The Role of Patient Assistance Programs

As drug prices continue to rise, patient assistance programs are becoming increasingly important in ensuring access to medications.

Impact on Net Pricing

While list prices may increase, patient assistance programs can significantly reduce the net price paid by patients. This dynamic creates a complex pricing environment where:

List prices may not reflect the actual cost to patients
Net prices may be substantially lower than publicly reported prices

Future of Patient Assistance Programs

The sustainability and evolution of patient assistance programs will play a crucial role in determining the effective price of drugs like NDC 42291-0822 for patients.

Global Market Considerations

While our focus has been primarily on the U.S. market, global market dynamics can also influence the pricing of NDC 42291-0822.

International Reference Pricing

Many countries use international reference pricing to set drug prices. This practice can create pressure on pharmaceutical companies to maintain consistent global pricing strategies.

Emerging Markets and Pricing Strategies

The growth of pharmaceutical markets in emerging economies may lead to:

Tiered pricing strategies
Volume-based agreements
Technology transfer arrangements

These global considerations may indirectly impact the pricing strategy for NDC 42291-0822 in the U.S. market.

The Future of Pharmaceutical Pricing: Key Trends to Watch

As we look towards 2025 and beyond, several key trends are likely to shape the future of pharmaceutical pricing, including for drugs like NDC 42291-0822.

1. Personalized Medicine and Pricing

The rise of personalized medicine and gene therapies is challenging traditional pricing models. We may see:

Outcome-based pricing agreements
Subscription models for long-term treatments
Tiered pricing based on genetic markers

2. Digital Health Integration

The integration of digital health technologies may lead to:

Real-time monitoring of drug efficacy
Dynamic pricing based on patient outcomes
Bundled pricing for drugs and digital health solutions

3. Sustainability and Green Pricing

Growing focus on environmental sustainability may influence pricing through:

Premiums for environmentally friendly manufacturing processes
Incentives for sustainable packaging and distribution
Carbon pricing considerations in drug development and production

Regulatory Outlook and Its Impact on Pricing

The regulatory landscape plays a crucial role in shaping pharmaceutical pricing strategies. As we approach 2025, several regulatory developments are worth monitoring.

Medicare Drug Price Negotiation Program

The implementation of this program, set to begin in 2026, could significantly impact the pricing of high-cost drugs covered by Medicare[6]. Key considerations include:

Selection criteria for drugs subject to negotiation
Potential ripple effects on private market pricing
Industry responses to maintain profitability

International Pricing Reforms

Global efforts to control drug prices may influence U.S. pricing strategies:

Reference pricing initiatives
Cross-border purchasing agreements
Harmonization of drug approval processes

Market Access Strategies in a Changing Landscape

As the pricing environment evolves, pharmaceutical companies will need to adapt their market access strategies to ensure commercial success for drugs like NDC 42291-0822.

Value Communication

Effectively communicating the value of a drug to payers, providers, and patients will be crucial. This may involve:

Real-world evidence generation
Health economic modeling
Patient-reported outcome measures

Innovative Contracting Models

To address pricing pressures and demonstrate value, companies may explore:

Outcomes-based contracts
Risk-sharing agreements
Subscription models for chronic treatments

The Role of Data Analytics in Price Optimization

Advanced data analytics will play an increasingly important role in pharmaceutical pricing strategies.

Predictive Pricing Models

Machine learning algorithms can help companies:

Forecast market demand
Simulate competitor responses
Optimize pricing across different market segments

Real-Time Price Adjustments

Dynamic pricing models, powered by AI, may enable:

Rapid response to market changes
Personalized pricing based on patient characteristics
Optimization of patient assistance programs

Key Takeaways

As we navigate the complex landscape of pharmaceutical pricing and project the future for drugs like NDC 42291-0822, several key points emerge:

Regular price increases are likely to continue, with an average of 7-10% annually in the short term.
Generic competition can lead to significant price erosion, potentially reducing prices by 70-80% within three years of market entry.
Technological advancements, including AI and blockchain, are reshaping pricing strategies and market dynamics.
Patient assistance programs play a crucial role in determining effective prices for patients.
Global market considerations, including international reference pricing, influence domestic pricing strategies.
The future of pharmaceutical pricing will be shaped by personalized medicine, digital health integration, and sustainability concerns.
Regulatory developments, particularly the Medicare Drug Price Negotiation Program, will have significant impacts on pricing strategies.
Effective market access strategies, including value communication and innovative contracting models, will be crucial for commercial success.
Advanced data analytics will enable more sophisticated and responsive pricing strategies.

As the pharmaceutical industry continues to evolve, staying informed about these trends and their potential impacts on specific drugs like NDC 42291-0822 will be essential for all stakeholders in the healthcare ecosystem.

FAQs

Q: How often do pharmaceutical companies typically increase drug prices? A: Pharmaceutical companies often implement price increases twice a year, typically in January and July. However, the frequency and magnitude of these increases can vary depending on market conditions and individual company strategies.
Q: What impact does generic competition have on brand-name drug prices? A: Generic competition can significantly reduce brand-name drug prices. Studies show that prices can decline by 70-80% relative to the pre-generic entry price in markets with 10 or more competitors within 3 years of generic entry.
Q: How might the Medicare Drug Price Negotiation Program affect drug pricing? A: The program, set to begin in 2026, could lead to lower prices for selected high-cost drugs covered by Medicare. This may have ripple effects on pricing in the private market and influence pharmaceutical companies' overall pricing strategies.
Q: What role does artificial intelligence play in pharmaceutical pricing? A: AI is increasingly used to optimize pricing strategies, predict market demand, simulate competitor responses, and enable real-time price adjustments based on various market factors.
Q: How do patient assistance programs affect drug pricing? A: Patient assistance programs can significantly reduce the net price paid by patients, creating a complex pricing environment where list prices may not reflect the actual cost to patients. These programs play a crucial role in ensuring access to medications while allowing companies to maintain higher list prices.

Sources cited: [1] https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory [2] https://aspe.hhs.gov/sites/default/files/documents/e9d5bb190056eb94483b774b53d512b4/price-tracking-brief.pdf [4] https://aspe.hhs.gov/sites/default/files/documents/510e964dc7b7f00763a7f8a1dbc5ae7b/aspe-ib-generic-drugs-competition.pdf [6] https://aspe.hhs.gov/sites/default/files/documents/3e8abec86039ac0ed674a8c5fac492e3/price-change-over-time-brief.pdf